Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Survival Endpoints for Treatment Evaluation in Subjects Treated for Metastatic Breast Cancer: Contribution of Real-life Databases

NCT03676257 is registered in ClinicalTrials.gov with Institut Bergonié as lead sponsor.

NCT NCT03676257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03676257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Survival Endpoints for Treatment Evaluation in Subjects Treated for Metastatic Breast Cancer: Contribution of Real-life Databases
Lead sponsor
Institut Bergonié
Phase
Observational
Overall status
Completed
Start date
January 1, 2008
Completion date
December 1, 2023
Enrollment
20,033 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer